NDC50242-0120-47: TENECTEPLASE FOR INJECTION KIT.
The TENECTEPLASE FOR INJECTION KIT is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: TENECTEPLASE INTRAVENOUS KIT, 50MG. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-691-6941, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | TENECTEPLASE INTRAVENOUS KIT, 50MG |
| NSN | 6505-01-691-6941 |
| SPECIAL FEATURES | INDICATED FOR USE IN THE REDUCTION OF MORTALITY ASSOCIATED WITH ACUTE MYOCARDIAL INFARCTION (AMI); TISSUE PLASMINOGEN ACTIVATOR (TPA) PRODUCED BY RECOMBINANT DNA TECHNOLOGY USING AN ESTABLISHED MAMMALIAN CELL LINE (CHINESE HAMSTER OVARY CELLS); STORE LYOPHILIZED TNKASE AT CONTROLLED ROOM TEMPERATURE NOT TO EXCEED 30 C (86 F) OR UNDER REFRIGERATION 2 TO 8 C (36 TO 46 F); DO NOT USE BEYOND THE EXPIRATION DATE STAMPED ON THE VIAL; FOR USE IN MYOCARDIAL INFARCTION; FOR INTRAVENOUS ADMINISTRATION ONLY; EACH KIT CONTAINS ONE 50 MG VIAIAL OF TNKASE, ONE 10 ML VIAL OF PRESERVATIVE-FREE STERILE WATER FOR INJECTION, USP, ONE BD 10 ML SYRINGE WITH TWINPAK DUAL CANNULA DEVICE, AND PACKAGE INSERT CONTAINING FULL PRESCRIBING INFORMATION; VIAL CONTENTS: THE PRESERVATIVE-FREE SINGLE-USE VIAL OF TNKASE CONTAINS 52.5 MG TENECTEPLASE, 0.55 G L-ARGININE, 0.17 G PHOSPHORIC ACID, AND 4.3 MG POLYSORBATE 20, UNDER PARTIAL VACUUM. NO U.S. STANDARD OF POTENCY; 36 MONTHS SHELF LIFE. G |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | TENECTEPLASE INTRAVENOUS KIT, 50MG |